Department profile
Latham & Watkins LLP

Life Sciences & Pharmaceutical Sector (International & Cross-Border)

Global Guide 2026 : USA


Latham & Watkins LLP

Rankings

Chambers Review

Provided by Chambers

Life Sciences & Pharmaceutical Sector (International & Cross-Border) - USA

Band 1

Band 1


What the Team is Known For

Latham & Watkins is recognised as an excellent option for clients that require counsel on highly complex and multifaceted cross-border matters. The firm provides an impressive, well-integrated team across its global offices and is praised for consistently excelling across multiple practice areas and sectors, while delivering an internationally oriented approach and comprehensive global support. The firm's efficient coordination across its international network is key to its appeal among high-profile multinational corporations, banks and investment funds.

With impressive cross-practice strength, Latham & Watkins is typically instructed on large transactional matters relating to the life sciences sector. The firm acts for numerous global pharmaceutical and biotechnology companies, assisting with IP and commercial agreements as part of large global mergers in the industry. The firm's strong client base among private equity funds also ensures it has the experience to handle all manner of investments and buyouts in the industry.

Strengths

Provided by Chambers

  • We have cross border issues and they are always able to help as they have unbelievable international expertise across the board.

    Life Sciences & Pharmaceutical Sector (International & Cross-Border) respondentGlobal

Notable Practitioners

Provided by Chambers

  • Band 1Peter N Handrinos
    Band 1Peter N Handrinos

    Peter N Handrinos

    Peter Handrinos is noted for his representation of investment banks and public companies in life sciences-related capital markets transactions and securities-related matters.
    • Pete is very practically minded. He provides good, balanced advice through the lens of the business objectives.

      Life Sciences & Pharmaceutical Sector (International & Cross-Border) respondentGlobal
  • Band 3Cheston Larson
    Band 3Cheston Larson

    Cheston Larson

    Cheston Larson advises biotech and other life sciences companies through all stages of their life cycle. His practice focuses on corporate and financing transactions. His work covers venture financing, IPOs and M&A transactions.

  • Band 3Jennifer Bragg
    Band 3Jennifer Bragg

    Jennifer Bragg

    Jennifer Bragg offers significant experience handling complex, high-stakes FDA enforcement matters. She regularly advises clients on internal and external investigations and conducts due diligence for major pharmaceutical companies.
  • Band 3John Manthei
    Band 3John Manthei

    John Manthei

    John Manthei advises pharmaceuticals, biotechnology and medical device companies on all manner of FDA and other regulatory procedures governing the life sciences sector. His expertise includes the negotiation of clinical trial agreements, pre-market product development and the regulation of marketing materials.
    • John is an FDA regulatory expert.

      Life Sciences & Pharmaceutical Sector (International & Cross-Border) respondentGlobal
  • Band 3Michael Morin
    Band 3Michael Morin

    Michael Morin

    Michael Morin is known for his extensive representations of large pharmaceutical companies in connection with patent and copyright infringement matters.

    • He is skilled in simplifying complex details and delivering engaging and understanding stories to a jury.

      Life Sciences & Pharmaceutical Sector (International & Cross-Border) respondentGlobal

Ranked Individuals at Latham & Watkins LLP (5)

USA

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership